Therapy News and Research

RSS

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Inspiration Biopharmaceuticals, Inc. today announced the initiation of patient enrollment in the second of two pivotal studies in the Company's OBI-1 Accur8 clinical trial program.

28 Nov 2011

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that they have initiated a Phase 3 clinical trial evaluating the efficacy and safety of EYLEA (aflibercept) Injection in the neovascular form of age-related macular degeneration (wet AMD) in China.

28 Nov 2011

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice.

28 Nov 2011

Exelixis and NCI's CTEP enter CRADA to further evaluate cabozantinib

Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.

28 Nov 2011

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.

28 Nov 2011

A very low calorie diet can effectively cure type 2 diabetes mellitus

A low-calorie diet eliminates insulin dependence and leads to improved heart function in obese patients with type 2 diabetes, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

28 Nov 2011

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

A new device that offers drug-free bedside filtered air flow can significantly reduce patients' symptoms such as wheezing and tight chests in asthmatics. The temperature controlled laminar airflow treatment, called Protexo, filters out airborne triggers such as dust particles and mites, pet hairs and powders that cause irritation and inflammation of the lungs.

27 Nov 2011

HGNS increases airflow during sleep in patients with OSA

Hypoglossal nerve stimulation (HGNS) produced marked dose-related increases in airflow in obstructive sleep apnea (OSA) patients without arousing them from sleep, according to a new study from the Johns Hopkins Sleep Disorders Center.

25 Nov 2011

Researchers take a step toward neuronal replacement therapy

A new study has revealed that immature neurons taken from healthy mouse embryos can repair damaged brain circuitry and partially normalize metabolism when transplanted into adult mice that have grown morbidly obese due to a genetic deficiency.

24 Nov 2011

Transplantation of tissue-engineered windpipe can benefit patients with tracheal cancer

Tracheal tumors can be surgically removed, but most are too large for the surgery to be successful by the time they are discovered. Therefore, new therapeutic options are needed. Even in patients with operable tumors, the proportion of complete tumor resection is less than 60%. This outcome would be greatly improved if a trachea substitute with similar anatomical, physiological and biomechanical properties of the patient's original trachea were available.

24 Nov 2011

Democrats ask Obama not to dilute contraceptive benefits

Democratic lawmakers, fearful that President Obama is on the verge of significantly diluting a proposed regulation that would give millions of women access to birth control without out-of-pocket insurance charges, are furiously lobbying the White House to hold the line.

24 Nov 2011

Obama should announce scale-up of AIDS treatment programs

Secretary of State Hillary Clinton's recent speech calling for an "AIDS-free generation" through the use of multiple prevention strategies, including more widespread antiretroviral therapy, "was a dramatic reversal of U.S. policy, which has historically viewed treatment more as a costly expense rather than our most powerful prevention investment," physician Loretta Ciraldo and Katrina Ciraldo, a student at Boston University School of Medicine, write in this Miami Herald opinion piece.

24 Nov 2011

Combination of radiation treatment and LY2109761 can prevent glioblastoma

Glioblastoma is regarded as the most malignant form of brain tumor. In many cases, neurosurgeons are not able to remove such tumors completely because of the risk of destroying too much brain tissue in the process. Moreover, it is often impossible to identify all the fine extensions by which the tumor spreads into surrounding healthy tissue. To at least slow down the growth of tumor cells that have remained in the head, almost all glioblastoma patients are treated by radiotherapy after surgery.

24 Nov 2011

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet.

24 Nov 2011

Two-drug combination may alleviate radiation sickness in people

A combination of two drugs may alleviate radiation sickness in people who have been exposed to high levels of radiation, even when the therapy is given a day after the exposure occurred, according to a study led by scientists from Dana-Farber Cancer Institute and Children's Hospital Boston.

24 Nov 2011

Stress chemicals shut down and brain processes emotional experiences during REM sleep

They say time heals all wounds, and new research from the University of California, Berkeley, indicates that time spent in dream sleep can help. UC Berkeley researchers have found that during the dream phase of sleep, also known as REM sleep, our stress chemistry shuts down and the brain processes emotional experiences and takes the painful edge off difficult memories.

24 Nov 2011

New First Choice infographic explores issue of SAD and winter blues

First Choice, one of the UK's leading leisure travel companies, has released an infographic that sheds light on how the lack of sunshine during the winter months is affecting a large proportion of the population in northern countries.

24 Nov 2011

Live cell encapsulation technology helps overcome obstacles facing applications of live stem cell usage

Nuvilex, Inc. announced today testing confirmed that through use of live cell encapsulation technology, two major obstacles facing the vast and broad applications of live stem cell use have been overcome.

23 Nov 2011

BIOTRONIK announces first implantations of new Lumax 740 ICDs

BIOTRONIK, a leading manufacturer of innovative medical technology, announced today the first implantations of the new Lumax 740 implantable cardiac defibrillators—the world's first and only ICDs eligible for use with magnetic resonance imaging.

23 Nov 2011

Mutations that affect lysosomes play a role in causing persistent stuttering

Researchers at Washington University School of Medicine in St. Louis have obtained new evidence that at least some persistent stuttering is caused by mutations in a gene governing not speech, but a metabolic pathway involved in recycling old cell parts.

23 Nov 2011

Therapy News and Research

Inspiration commences enrollment in second OBI-1 Accur8 clinical trial program for congenital hemophilia A

Bayer, Regeneron commence EYLEA Phase 3 clinical trial for wet AMD in China

Henry Schein launches new integrated comprehensive solution to treat sleep apnea

Exelixis and NCI's CTEP enter CRADA to further evaluate cabozantinib

Inspiration initiates second OBI-1 phase III clinical trial in congenital hemophilia A with inhibitors

A very low calorie diet can effectively cure type 2 diabetes mellitus

Laminar air flow therapy via novel device could be beneficial for asthmatics: Study

HGNS increases airflow during sleep in patients with OSA

Researchers take a step toward neuronal replacement therapy

Transplantation of tissue-engineered windpipe can benefit patients with tracheal cancer

Democrats ask Obama not to dilute contraceptive benefits

Obama should announce scale-up of AIDS treatment programs

Combination of radiation treatment and LY2109761 can prevent glioblastoma

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Two-drug combination may alleviate radiation sickness in people

Stress chemicals shut down and brain processes emotional experiences during REM sleep

New First Choice infographic explores issue of SAD and winter blues

Live cell encapsulation technology helps overcome obstacles facing applications of live stem cell usage

BIOTRONIK announces first implantations of new Lumax 740 ICDs

Mutations that affect lysosomes play a role in causing persistent stuttering

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News